Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HDM1005

Phase Ia Clinical Study of HDM1005 Injection

Huadong Medicine · Phase 1 · Completed · Enrollment 65

NCT06640647

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
HDM1005 injection dose level 1n/rn/rn/rn/r
HDM1005 injection dose level 2n/rn/rn/rn/r
HDM1005 injection dose level 3n/rn/rn/rn/r
HDM1005 injection dose level 4n/rn/rn/rn/r
HDM1005 injection dose level 5n/rn/rn/rn/r
HDM1005 injection dose level 6n/rn/rn/rn/r
HDM1005 injection dose level 7n/rn/rn/rn/r

Not shown

  • HDM1005 injection dose level 1: endpoint not reported
  • HDM1005 injection dose level 2: endpoint not reported
  • HDM1005 injection dose level 3: endpoint not reported
  • HDM1005 injection dose level 4: endpoint not reported
  • HDM1005 injection dose level 5: endpoint not reported
  • HDM1005 injection dose level 6: endpoint not reported
  • HDM1005 injection dose level 7: endpoint not reported